Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indices continue to trade weak
Thu, 31 Jan 01:30 pm

Indian stock market, continued to trade in the red during the last two hours of trade. Barring select stocks from the FMCG and realty spaces, selling activity is being witnessed across the board. Stocks from the metals, IT and oil and gas sectors are amongst the top losers at the moment.

BSE-Sensex is down by 80 points and NSE-Nifty is trading down by 14 points. While the BSE Mid Cap is trading down by 0.01%, the BSE Small Cap index is trading down by 0.15%. The rupee is trading at 53.36 to the US dollar.

Pharma stocks are trading mixed with Panacea Biotech and Dishman Pharma being among the top gainers and Strides Acrolab and Ranbaxy Ltd being among the losers. Ipca Laboratories announced its 3QFY13 results. Net sales grew by 15% YoY during the quarter led by growth in both its formulations and API businesses. The company witnessed robust growth in its Export API business, which grew by 30% YoY for the quarter. Export formulations grew by 10% YoY on back of lower sales from the UK segment for the quarter. The domestic formulations and domestic API business grew by 13% YoY and 12% YoY respectively for 3QFY13. The operating margins declined by 1.2% largely due to increase in expenses related to its SEZ facility. At the profit after tax (PAT) level, the company witnessed growth of 37.5% YoY, which was due to lower forex loss in 3QFY13. The stock was trading up by 1%.

FMCG stocks are trading mixed with Colgate and Godrej Consumer being the biggest losers and Lakshmi Energy and Archies leading the gains. Colgate has declared its financial results for the quarter ended December 2012. The company recorded a 14% YoY increase in sales during the quarter. However, its operating margins contracted by 220 basis points (2.2%) to 19% on account of a steep rise in advertisement expenditure along with higher input costs and staff costs. At the net level, Colgate's earnings dipped by 4% due to a marginal 2.4% rise in operating profit and 5.6% reduction in other income earned during the quarter. Even the tax outgo rose by 19% as a result of higher tax incidence, reducing net profits for the quarter. The stock is trading down by 3.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indices continue to trade weak". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.